CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

Sigma Healthcare shares drop as leading Australian Pharmaceutical distributor proposes a merger

Shares of pharmaceutical company Sigma fell upon news of a possible merger with leading pharma distributor API

IG Analyst

Publication date : 2018-12-14T00:13:26+0000

API mergers with Sigma

Leading drug distributorAustralian Pharmaceutical Industries Ltd (API) offered A$727 million to Sigma healthcare.

API announced its proposal to buy Sigma on Friday, offering A$0.686 per Sigma share, and API shareholders owning 63% of the combined entity if the deal was to go ahead.

API already owns Australia’s leading pharmacy and beauty supply chain, Priceline and Priceline Pharmacy, while Sigma owns lesser-known pharmacy companies Amcal, Chemist King, Guardian and Discount Drug stores.

If the deal was to go ahead, API would own the majority of Australia’s leading healthcare pharmacies. API already owns a 13% share in Sigma healthcare limited.

API says it intends to ensure that it holds strategic options in the future shape of the healthcare industry.

“API’s preference is to take the next steps with Sigma so that all shareholders can share in the benefits of a merged entity. The NBIO is conditional on, among other things, completion of due diligence and ACCC clearance.” API said in a statement.

If an agreement is reached with Sigma it will go through regulatory processes that could run throughout 2019.

API will now await engagement with the Sigma Board to allow the full merger to be reviewed.

Sigma Pharmaceutical shares fall

Sigma Healthcare Ltd shares have fallen upon the proposed merger, dropping up to 3.5% at time of writing on Friday.

Analysts predict the shares to continue to drop upon the news.

While API shares remained strong and unaffected by the announcement, healthcare stocks were down 0.7% just after open on Friday.

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IG Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.

Find articles by writer

Disclaimer:

All forms of investments carry risks and trading CFDs may not be suitable for everyone. CFDs are leveraged instruments and can result in losses that exceed deposits, so please ensure that you fully understand, and are aware of, the risks and costs involved. Refer to the Risk Disclosure Statement and Risk Fact Sheet.

IG Asia Pte Ltd (Co.Reg.No. 200510021K) is regulated by the Monetary Authority of Singapore and holds a capital markets services licence for dealing in capital markets products that are over-the-counter derivatives contracts and is an exempt financial adviser.

IG provides an execution-only service. The information in this advertisement does not contain (and should not be construed as containing) investment advice or an investment recommendation, or an offer of or solicitation for a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. You should consider your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

The information on this site is not directed at residents of the United States or Belgium and is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

This advertisement has not been reviewed by the Monetary Authority of Singapore.